Medicare Enrolled
Dr. Igor Ryndin, MD
Urology Physician · Brooklyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ryndin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ryndin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ryndin
Dr. Igor Ryndin is an urology physician in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ryndin performed 7,001 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ryndin received a total of $10,614 from 41 pharmaceutical and/or device companies across 544 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ryndin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 13% volume in NY
$10,614 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,001
Medicare services
Top 13% in NY for urology physician
Not available
Unique patients (not deduplicated)
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,827 | $77 | $150 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
581 | $8 | $25 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
519 | $44 | $100 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
488 | $12 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
462 | $69 | $300 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
396 | $97 | $500 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
380 | $123 | $300 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
343 | $90 | $200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
303 | $103 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
288 | $50 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
235 | $96 | $300 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
167 | $220 | $600 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 138 | $128 | $887 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
133 | $88 | $400 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
131 | $52 | $300 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
122 | $10 | $100 |
| Complicated insertion of bladder tube | 79 | $124 | $300 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
73 | $43 | $300 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
46 | $52 | $652 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
46 | $29 | $300 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
41 | $352 | $1,000 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
41 | $29 | $1,000 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
41 | $176 | $600 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
39 | $220 | $500 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
32 | $298 | $1,000 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $157 | $1,000 |
| Endoscopic removal of urethral or bladder foreign body A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract. |
16 | $428 | $3,000 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
16 | $365 | $2,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
24.4% medium
75.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,614
Total received (2018-2024)
Avg $1,516/year across 7 years
Top 18% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
544
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,290
2023
$1,795
2022
$1,961
2021
$1,193
2020
$1,268
2019
$1,475
2018
$1,630
Payments by company (2024)
Sumitomo Pharma America, Inc.
$762
Astellas Pharma US Inc
$142
PFIZER INC.
$141
Boston Scientific Corporation
$58
Verity Pharmaceuticals Inc.
$33
ABBVIE INC.
$26
CIVCO Medical Instruments
$26
Myriad Genetic Laboratories, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
Hologic Sales and Service, LLC
$21
DENTSPLY IH AB
$19
Tolmar, Inc.
$18
Top 3 companies account for 81.0% of 2024 payments
All-time payments by company (2018-2024) ›
Sumitomo Pharma America, Inc.
$1,763
Astellas Pharma US Inc
$1,694
Boston Scientific Corporation
$1,098
UROVANT SCIENCES INC
$1,044
PFIZER INC.
$919
NeoTract Inc.
$602
Coloplast Corp
$514
Endo Pharmaceuticals Inc.
$328
BOSTON SCIENTIFIC CORPORATION
$240
Axonics Modulation Technologies, Inc.
$232
Allergan Inc.
$214
TOLMAR Pharmaceuticals, Inc.
$209
Myovant Sciences Inc.
$151
Janssen Biotech, Inc.
$144
Allergan, Inc.
$143
ABBVIE INC.
$135
Medtronic, Inc.
$127
Myriad Genetic Laboratories, Inc.
$121
Verity Pharmaceuticals Inc.
$86
Tolmar, Inc.
$82
Merck Sharp & Dohme Corporation
$78
Bayer HealthCare Pharmaceuticals Inc.
$76
AbbVie Inc.
$68
DENTSPLY IH Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$56
Laborie Medical Technologies Corp.
$55
Teleflex LLC
$40
Merck Sharp & Dohme LLC
$37
Ethicon US, LLC
$34
180 Medical, Inc.
$34
CIVCO Medical Instruments
$26
AbbVie, Inc.
$24
Ferring Pharmaceuticals Inc.
$23
Foundation Medicine, Inc.
$22
Hologic Sales and Service, LLC
$21
Blue Earth Diagnostics Limited
$20
Clarus Therapeutics Inc.
$19
DENTSPLY IH AB
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
Antares Pharma, Inc.
$17
Avadel Specialty Pharmaceuticals, LLC
$17
Top 3 companies account for 42.9% of all-time payments
Associated products mentioned in payments ›
AMS · APTIMA · AVEED · Androgel · Axonics r-SNM System · Axumin · BOTOX · BOTOX - UROLOGY · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL THERAPIES · GENERAL - BPH · GENERAL - ERECTILE DYSFUNCTION · GENERAL - KIDNEY STONE DISEASE · GENERAL BPH · ILLUMISITE · JATENZO · KAPSPARGO · KEYTRUDA · LOFRIC · LUPRON DEPOT · LoFric · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · PROLARIS · Prolaris · REZUM · Rezum Generator · SPACEOAR · SpaceOAR VUE System - 10mL · Surgicel Powder · TITAN · TOVIAZ · Trelstar · UROLIFT · UroLift · UroLift System · Veozah · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
692
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ryndin is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ryndin experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ryndin performed 1,827 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ryndin receive payments from pharmaceutical companies?
Yes. Dr. Ryndin received a total of $10,614 from 41 companies across 544 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ryndin's costs compare to other urology physicians in Brooklyn?
Dr. Ryndin's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ryndin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Brooklyn
Browse urology physicians in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology